Dediabetes Logo
Evidence Hub
Learn what works
Evidence Explorer
Search the complete evidence graph
Clinical Reference
Detailed intervention and outcome dossiers
Latest Research
Newest studies
What Changed
Weekly intelligence
Settings
Login / Sign-up
Research Summary
Analyzed using Evidence Intelligence™

Higher Fiber Intake Improves Glycemic Control in Type 2 Diabetes

Powered by the Dediabetes Evidence Intelligence™ framework

Last updated August 22, 2026

Key finding

Higher intake of total fiber was positively associated with better β-cell function (β = 1.694, P = 0.024).

This study analyzed the impact of dietary fiber intake on clinical outcomes in patients with Type 2 diabetes, revealing positive associations with various health metrics.

Quick read

Study at a glance

The essential study design details in one scan.

EvidenceScore™

Moderate

Study type

RCTs

Follow-up

Extended (5–20+ y)

Risk of bias

Some Concerns

Save research, organize studies, and quickly find important evidence again.

Plain-language summary

What this paper says

A plain-language read of the study’s main message and where it applies.

Study focus

This study analyzed the impact of dietary fiber intake on clinical outcomes in patients with Type 2 diabetes, revealing positive associations with various health metrics.

Clinical relevance

These findings highlight the importance of dietary choices in managing Type 2 diabetes. By increasing fiber intake, patients may improve their metabolic health and reduce complications associated with diabetes, making dietary fiber a crucial component of diabetes management strategies.

Keep in mind

The effectiveness of interventions remains unclear due to the observational nature of the analysis. Results may not be generalizable to all populations with Type 2 diabetes. Potential confounding factors were not fully controlled for in the analysis.

Published in

Journal Reference

Publication details and source links for this paper.

Jia L, Yu A, Ning Y, Yuan X, Guang W. Dietary Fiber Intake and Clinical Outcomes in Patients with Type 2 Diabetes: A Secondary Analysis of the MARCH Trial. Nutrition & Diabetes. 2024;14:81. doi:10.1038/s41387-024-00340-z

View DOIView on PubMedView on PMC

Main Effects

Higher total fiber intake was positively associated with improved beta-cell function (effect size: 1.694, p=0.024).

Increased legume fiber intake correlated with better weight loss under metformin treatment (effect size: -0.052 kg, p=0.024).

A high-carbohydrate–low-fiber diet was linked to worse glycemic control under acarbose treatment (effect size: -0.059, p=0.028).

Evidence network

How this study fits

Understand where this research contributes within the broader evidence network.

Evidence Context

This study contributes evidence to Acarbose, Metformin and Beta-cell function, Carbohydrate-to-fiber ratio and glycemic control, Insulin sensitivity, and 3 more.

This study contributes evidence to

Intervention

Acarbose

Outcome

Beta-cell function

Evidence topic

Insulin Resistance

Primary intervention

Acarbose

Primary outcomes

  • Beta-cell function
  • Carbohydrate-to-fiber ratio and glycemic control
  • Insulin sensitivity

Evidence topics

Insulin ResistancePrediabetesCardiometabolic RiskAlpha-glucosidase Inhibitors

Primary intervention

Acarbose

Primary outcomes

Beta-cell functionCarbohydrate-to-fiber ratio and glycemic controlInsulin sensitivity

Evidence relationships

Intervention and outcome relationships this study adds to the evidence network.

6
Evidence pairs
6
Relationships
5
Evidence topics
contributes_evidence

Editorial context

Why this study matters

See why this paper is useful beyond its individual results.

Evidence network role

This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.

Moderate contributionModerate confidenceNetwork score: 68

5

Related topics

6

Evidence pairs

901

Related studies

High relevance in at least one topic

Why it is useful

  • Contributes to 6 evidence relationships
  • Includes primary outcome data
  • Linked to 5 direct semantic evidence topics

Topic contributions

Evidence topic

Contributes evidence

Evidence topic

Contributes evidence

Evidence topic

Contributes evidence

Evidence topic

Contributes evidence

Add related evidence to your Evidence Tracker

Save studies and evidence pages, organize your personal Evidence Tracker, and keep the research you care about in one place.

Primary evidence

Evidence relationship

Alpha-glucosidase inhibitors and Insulin Resistance

Related evidence

Evidence relationship

Metformin Therapies and Blood Pressure

Save evidence

Evidence relationship

Alpha-glucosidase inhibitors and Beta-cell Function

Save evidence

Core evidence

Study findings

The primary outcomes reported in this study.

Beta-cell function

Acarbose → Beta-cell function

Acarbose → Beta-cell function

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Carbohydrate-to-fiber ratio and glycemic control

Acarbose → Carbohydrate-to-fiber ratio and glycemic control

Acarbose → Carbohydrate-to-fiber ratio and glycemic control

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Insulin sensitivity

Acarbose → Insulin sensitivity

Acarbose → Insulin sensitivity

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Postprandial glycemic response to a mixed meal

Acarbose → Postprandial glycemic response to a mixed meal

Acarbose → Postprandial glycemic response to a mixed meal

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Diastolic blood pressure

Metformin → Diastolic blood pressure

Metformin → Diastolic blood pressure

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Weight loss dependent effect on HbA1c

Metformin → Weight loss dependent effect on HbA1c

Metformin → Weight loss dependent effect on HbA1c

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
25
Negative
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Evidence Library

Build your evidence library

Save research, organize studies, and quickly find important evidence again.

evidence suggest

Evidence Suggest

  • Total fiber intake improved insulin sensitivity (effect size: 2.988, p=0.006).
  • Legume fiber intake was associated with better glycemic control under both acarbose and metformin.
  • Higher whole grain fiber intake was linked to increased diastolic blood pressure under metformin treatment.
who this applies

Who this applies to

  • Adults diagnosed with Type 2 diabetes.
  • Patients undergoing treatment with acarbose or metformin.
keep in mind

Keep in Mind

  • The study's findings are based on a secondary analysis and may not establish causation.
  • Dietary fiber sources varied, and specific types may have different effects.
  • Further research is needed to confirm these findings across diverse populations.
between the lines

Between the Lines

  • The effectiveness of interventions remains unclear due to the observational nature of the analysis.
  • Results may not be generalizable to all populations with Type 2 diabetes.
  • Potential confounding factors were not fully controlled for in the analysis.

Evidence Library

Build your evidence library

Save research, organize studies, and quickly find important evidence again.

Connected Evidence

Explore related studies, evidence collections, and research questions.

Relationships organized using the Dediabetes Evidence Intelligence™ framework.

Powered by the Dediabetes Evidence Intelligence™ framework

This study contributes to evidence on Metformin Therapies and Insulin Resistance, Alpha-glucosidase inhibitors and Beta-cell Function.

Related evidence relationships

Explore in Evidence Explorer

This study contributes to the evidence on the following intervention-outcome relationships.

Included in these evidence collections

Curated evidence collections and hubs this study is part of.

Insulin Resistance Evidence Hub

All studies measuring Insulin Resistance

2 studies
outcome_hub

Measures Insulin Resistance as a key outcome.

Metformin Therapies Evidence Hub

All studies on Metformin Therapies

2 studies
intervention_hub

Contributes to Metformin Therapies evidence base.

Alpha-glucosidase inhibitors Evidence Hub

All studies on Alpha-glucosidase inhibitors

1 studies
intervention_hub

Contributes to Alpha-glucosidase inhibitors evidence base.

Beta-cell Function Evidence Hub

All studies measuring Beta-cell Function

1 studies
outcome_hub

Measures Beta-cell Function as a key outcome.

Blood Pressure Evidence Hub

All studies measuring Blood Pressure

1 studies
outcome_hub

Measures Blood Pressure as a key outcome.

Questions answered by this study

Generated from the study's connected evidence using Evidence Intelligence™.

Does Alpha-glucosidase inhibitors improve insulin resistance?

Strong Evidence

Alpha-glucosidase inhibitors may improve Insulin Resistance.

ConsistencyScore™: Results are mixed and should be interpreted cautiously.

Evidence caveat: The available evidence reports mixed findings.

Ranked evidence signals

  1. 1

    Insulin sensitivity

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is cautious because the available studies report mixed findings.

Limitations

  • Population details are unavailable.
3 supporting studiesUpdated: Aug 2026
View Full Evidence

Does Metformin Therapies improve blood pressure?

Strong Evidence

Metformin Therapies may improve Blood Pressure.

ConsistencyScore™: Results are generally consistent across studies.

Ranked evidence signals

  1. 1

    Diastolic blood pressure

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on 3 supporting studies with generally consistent results and a positive effect signal.

Limitations

  • Population details are unavailable.
3 supporting studiesUpdated: Aug 2026
View Full Evidence

Does Alpha-glucosidase inhibitors improve beta-cell function?

Emerging Evidence

Alpha-glucosidase inhibitors appears to improve Beta-cell Function.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Beta-cell function

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Consistency cannot yet be determined.
  • Population details are unavailable.
1 supporting studyUpdated: Aug 2026
View Full Evidence

Does Acarbose improve postprandial glycemic response to a mixed meal?

Emerging Evidence

Acarbose appears to improve Postprandial glycemic response to a mixed meal.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Postprandial glycemic response to a mixed meal

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Consistency cannot yet be determined.
  • Population details are unavailable.
1 supporting studyUpdated: Aug 2026
View Full Evidence
Learn how Evidence Intelligence™ works

Next steps

Continue your research

Choose a next path through related evidence topics, Evidence Explorer views, and research summaries.

Evidence topics

Follow the topics this study contributes to.

Insulin Resistance Evidence HubPrediabetes Evidence HubCardiometabolic Risk Evidence HubAlpha-glucosidase Inhibitors Evidence Hub

Explore in Evidence Explorer

Open broader Evidence Explorer views for this relationship.

All studies on Acarbose and Beta-cell functionAll studies on Acarbose and Insulin sensitivityAll studies on Acarbose and Postprandial glycemic response to a mixed mealAll studies on Metformin and Weight loss dependent effect on HbA1c

Related research

Read related research summaries.

Carnosine shows little effect on cardiovascular outcomes in diabetesDietary Modulation of Gut Microbiota in PrediabetesVildagliptin and Metformin Improve Glycemic Control in Type 2 DiabetesEarly use of effective therapies may improve diabetes outcomesGlucose variability increases with age in type 2 diabetes patients

No ads. No tracking.

Focused on evidence, not advertising.

Secure & private

Your data is always protected.

Always up to date

New studies added every day.